Brief: Nektar Therapeutics Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing
28/03/2025 20:24
March 28 (Reuters) - Nektar Therapeutics NKTR.O: NEKTAR THERAPEUTICS: FILES FOR MIXED SHELF OFFERING OF UP TO $300 MILLION - SEC FILING Source text: [ID:n0001193125-25-067122] Further company coverage: NKTR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nektar Therapeutics
See all newsBrief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio
U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says